Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bloomfield

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Medicinal Chemistry|September 3, 2004
Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide coreTimothy J Ritchie, Edward K Dziadulewicz, Andrew J Culshaw, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2012
Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathwayIan Bruce, Mohammed Akhlaq, Graham C Bloomfield, et al.
Journal of Medicinal Chemistry|March 15, 2000
1-(2-Nitrophenyl)thiosemicarbazides: a novel class of potent, orally active non-peptide antagonist for the bradykinin B(2) receptorE K Dziadulewicz, T J Ritchie, A Hallett, et al.
British Journal of Pharmacology|February 29, 2000
Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesiaG M Burgess, M N Perkins, H P Rang, et al.
Journal of Medicinal Chemistry|May 17, 2002
Nonpeptide bradykinin B2 receptor antagonists: conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonistsEdward K Dziadulewicz, Timothy J Ritchie, Allan Hallett, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Medicinal Chemistry|September 3, 2004
Potent and orally bioavailable non-peptide antagonists at the human bradykinin B(1) receptor based on a 2-alkylamino-5-sulfamoylbenzamide coreTimothy J Ritchie, Edward K Dziadulewicz, Andrew J Culshaw, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2012
Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathwayIan Bruce, Mohammed Akhlaq, Graham C Bloomfield, et al.
Journal of Medicinal Chemistry|March 15, 2000
1-(2-Nitrophenyl)thiosemicarbazides: a novel class of potent, orally active non-peptide antagonist for the bradykinin B(2) receptorE K Dziadulewicz, T J Ritchie, A Hallett, et al.
British Journal of Pharmacology|February 29, 2000
Bradyzide, a potent non-peptide B(2) bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesiaG M Burgess, M N Perkins, H P Rang, et al.
Journal of Medicinal Chemistry|May 17, 2002
Nonpeptide bradykinin B2 receptor antagonists: conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonistsEdward K Dziadulewicz, Timothy J Ritchie, Allan Hallett, et al.
Pageof 4